Cognitive Behaviour Therapy for Patients With IBS

NCT00788658 | Completed DMC

• 1 other identifier: RMC 5139
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

Irritable bowel syndrome (IBS) affects approximately 10-15% of the adult population. This condition is characterized by abdominal pain, altered bowel habit, abdominal bloating and reduced quality of life. Options for treating IBS include pharmacotherapy, psychotherapy, hypnotherapy and cognitive behavior therapy (CBT). Available data on the effectiveness of CBT in IBS patients in Israel are scarce. The aim of the present study is to assess effectiveness of CBT as compared with standard therapy for IBS patients in Israel The course of CBT consisted of up to six 40 min sessions, and included education about IBS and techniques to reduce focusing on symptoms and to manage stress.Standard therapy includs life style modifications. The primary outcome measure was the score on a symptom-severity scale specific to IBS.

Conditions

Irritable Bowel Syndrome; Constipation; Abdominal Pain; Depression

Keywords

Obstructed constipation; Quality of life

Outcome Measures

Primary Outcomes (1)

• Symptom score

  3 months

Secondary Outcomes (1)

• Quality of life assessment

  3 months

Study Arms (2)

Diet modifications

PLACEBO COMPARATOR

Diet consultation and life style modifications for 6 sessions

Behavioral: Diet modifications

Cognitive therapy

ACTIVE COMPARATOR

6 sessions of cognitive behavioral therapy

Behavioral: Cognitive behavioral therapy

Interventions

Diet modifications BEHAVIORAL

Diet consultation

Also known as: Diet

Diet modifications

Cognitive behavioral therapy BEHAVIORAL

Cognitive behavioral therapy

Also known as: CBT

Cognitive therapy

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 18-75
• IBS

You may not qualify if:

• Malignancy
• Known psychiatric disorders

Sponsors & Collaborators

• Rabin Medical Center: lead

MeSH Terms

Conditions

Irritable Bowel Syndrome; Constipation; Abdominal Pain; Depression

Interventions

Diet Therapy; Diet; Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Colonic Diseases, Functional; Colonic Diseases; Intestinal Diseases; Gastrointestinal Diseases; Digestive System Diseases; Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Behavioral Symptoms; Behavior

Intervention Hierarchy (Ancestors)

Nutrition Therapy; Therapeutics; Nutritional Physiological Phenomena; Diet, Food, and Nutrition; Physiological Phenomena; Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Ram Dickman, MD

  RMC

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: November 10, 2008
• First Posted: November 11, 2008
• Study Start: December 1, 2008
• Primary Completion: December 1, 2010
• Study Completion: December 1, 2010
• Last Updated: April 13, 2016

Record last verified: 2016-04